TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | (Q6)Sep 30, 2020 | (FY)Mar 31, 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -20.45%-7.82M | ---- | -292.87%-6.49M | ---- | 145.89%3.36M | ---- | 34.12%-7.33M | 94.66%-187K | -68.68%-11.13M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | -53.27%-679K | ---- | -14,666.67%-443K | ---- | 95.38%-3K | ---- | 85.96%-65K | 82.63%-45K | -31.53%-463K |
Impairment and provisions: | ---- | -59.31%623K | ---- | 1,068.70%1.53M | ---- | 551.72%131K | ---- | -105.01%-29K | 8.70%-21K | 112.09%579K |
-Impairmen of inventory (reversal) | ---- | -59.31%623K | ---- | 1,068.70%1.53M | ---- | 551.72%131K | ---- | -105.01%-29K | 8.70%-21K | 112.09%579K |
Revaluation surplus: | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --27K | ---- | ---- |
-Other fair value changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --27K | ---- | ---- |
Asset sale loss (gain): | ---- | ---- | ---- | ---- | ---- | ---245K | ---- | ---- | ---- | ---50K |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---2K |
-Loss (gain) from selling other assets | ---- | ---- | ---- | ---- | ---- | ---245K | ---- | ---- | ---- | ---48K |
Depreciation and amortization: | ---- | -38.36%1.08M | ---- | 10.61%1.75M | ---- | -3.24%1.58M | ---- | -65.68%1.64M | -63.69%809K | 96.05%4.77M |
Financial expense | ---- | 57.69%41K | ---- | -13.33%26K | ---- | -38.78%30K | ---- | 19.51%49K | 28.57%27K | 64.00%41K |
Exchange Loss (gain) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --14K | ---- |
Unrealized exchange loss (gain) | ---- | -12.69%117K | ---- | -39.09%134K | ---- | 2,300.00%220K | ---- | ---10K | ---- | ---- |
Special items | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --313K | ---- | ---- |
Operating profit before the change of operating capital | ---- | -90.17%-6.63M | ---- | -168.65%-3.49M | ---- | 193.95%5.08M | ---- | 13.46%-5.41M | 137.69%597K | -48.19%-6.25M |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | 94.28%-109K | ---- | -8,033.33%-1.9M | ---- | -89.66%24K | ---- | 176.32%232K | -136.36%-78K | 76.76%-304K |
Accounts receivable (increase)decrease | ---- | -402.47%-4.66M | ---- | -11.55%1.54M | ---- | 184.84%1.74M | ---- | -144.67%-2.05M | -540.40%-6.54M | 420.27%4.59M |
Accounts payable increase (decrease) | ---- | -756.10%-1.08M | ---- | 121.95%164K | ---- | -121.70%-747K | ---- | 982.56%3.44M | 646.97%3.94M | -180.58%-390K |
prepayments (increase)decrease | ---- | 1,208.33%157K | ---- | -83.33%12K | ---- | 111.46%72K | ---- | -240.49%-628K | -121.76%-479K | -82.71%447K |
Special items for working capital changes | ---- | 91.30%-153K | ---- | -245.65%-1.76M | ---- | 548.92%1.21M | ---- | -42.24%186K | --224K | 40.61%322K |
Cash from business operations | ---- | -129.52%-12.47M | ---- | -173.65%-5.43M | ---- | 274.50%7.38M | ---- | -167.59%-4.23M | -2,320.95%-2.33M | -17.56%-1.58M |
Other taxs | ---- | 150.75%34K | ---- | 12.99%-67K | ---- | -3,950.00%-77K | ---- | -99.85%2K | ---4K | 200.97%1.36M |
Special items of business | 117.81%1.45M | -57.69%-41K | -21.29%-8.11M | 13.33%-26K | -335.99%-6.69M | 38.78%-30K | 10,596.30%2.83M | -19.51%-49K | -28.57%-27K | -64.00%-41K |
Net cash from operations | 117.81%1.45M | -125.78%-12.48M | -21.29%-8.11M | -176.01%-5.53M | -335.99%-6.69M | 270.08%7.27M | 219.93%2.83M | -1,537.93%-4.28M | -536.93%-2.36M | 90.39%-261K |
Cash flow from investment activities | ||||||||||
Interest received - investment | ---- | 53.27%679K | ---- | 14,666.67%443K | ---- | -95.38%3K | ---- | -85.96%65K | -82.63%45K | 31.53%463K |
Decrease in deposits (increase) | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 200.00%125K |
Sale of fixed assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --2K |
Purchase of fixed assets | ---- | 91.98%-34K | ---- | -1,414.29%-424K | ---- | 94.66%-28K | ---- | -682.09%-524K | -613.46%-371K | 99.12%-67K |
Selling intangible assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --400K |
Recovery of cash from investments | ---- | ---- | ---- | ---- | ---- | --10.59M | ---- | ---- | ---- | ---- |
Cash on investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---10.37M | ---2.57M | ---- |
Other items in the investment business | -26.27%275K | ---- | 236.13%373K | ---- | -102.59%-274K | ---- | --10.56M | ---- | ---- | ---- |
Net cash from investment operations | -26.27%275K | 3,294.74%645K | 236.13%373K | -99.82%19K | -102.59%-274K | 197.54%10.56M | 464.39%10.56M | -1,273.02%-10.83M | -575.86%-2.9M | 112.47%923K |
Net cash before financing | 122.23%1.72M | -114.85%-11.83M | -11.16%-7.74M | -130.89%-5.51M | -151.98%-6.96M | 218.08%17.83M | 354.59%13.39M | -2,381.27%-15.1M | -2,310.50%-5.26M | 106.54%662K |
Cash flow from financing activities | ||||||||||
Other items of the financing business | 10.59%-304K | ---- | 6.85%-340K | ---- | -2.82%-365K | ---- | ---355K | ---- | ---- | ---- |
Net cash from financing operations | 10.59%-304K | 6.28%-671K | 6.85%-340K | 0.00%-716K | -2.82%-365K | -2.73%-716K | -2.60%-355K | 7.07%-697K | 38.10%-346K | -371.70%-750K |
Effect of rate | -172.95%-178K | 3,633.33%112K | 92.13%244K | 101.24%3K | 735.00%127K | -706.67%-242K | -300.00%-20K | -25.00%-30K | 80.77%-5K | -26.32%-24K |
Net Cash | 117.53%1.42M | -100.92%-12.51M | -10.26%-8.08M | -136.36%-6.22M | -156.19%-7.33M | 208.34%17.12M | 332.55%13.04M | -17,853.41%-15.8M | -1,646.73%-5.61M | 99.14%-88K |
Begining period cash | -47.58%13.65M | -19.28%26.04M | -19.28%26.04M | 109.64%32.27M | 109.64%32.27M | -50.70%15.39M | -50.70%15.39M | -0.36%31.22M | -0.36%31.22M | -24.73%31.33M |
Cash at the end | -18.23%14.89M | -47.58%13.65M | -27.35%18.21M | -19.28%26.04M | -11.77%25.07M | 109.64%32.27M | 10.94%28.41M | -50.70%15.39M | -17.35%25.61M | -0.36%31.22M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.